Timothée Bruel
- Virology top 1%
- HIV Research and Treatment 24
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research 18
- COVID-19 Clinical Research Studies 14
- SARS-CoV-2 detection and testing 8
- Immunology top 5%
- Immune Cell Function and Interaction 21
- T-cell and B-cell Immunology 10
- Immunotherapy and Immune Responses 6
- Modeling and Simulation top 5%
- Animal Science and Zoology top 5%
-
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- Olivier SchwartzNicoletta CasartelliHugo MouquetFlorence Guivel‐BenhassineFrançoise PorrotJérémy DuflooCyril PlanchaisDelphine Planas
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Timothée Bruel
52 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Virology 740
- Infectious Diseases 1.1k
- Immunology 907
- Modeling and Simulation 57
- Animal Science and Zoology 121
Countries citing papers authored by Timothée Bruel
This map shows the geographic impact of Timothée Bruel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothée Bruel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothée Bruel more than expected).
Fields of papers citing papers by Timothée Bruel
This network shows the impact of papers produced by Timothée Bruel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothée Bruel. The network helps show where Timothée Bruel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Timothée Bruel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 6 | |
| 4 | 2022 | 14 | |
| 5 | 2022 | 7 | |
| 6 | 2022 | 23 | |
| 7 | 2022 | 37 | |
| 8 | 2021 | 49 | |
| 9 | Syncytia formation by SARS‐CoV‐2‐infected cellsbreakdown → | 2021 | 243 |
| 10 | 2020 | 266 | |
| 11 | 2020 | 67 | |
| 12 | 2019 | 16 | |
| 13 | 2018 | 76 | |
| 14 | 2018 | 19 | |
| 15 | 2018 | 41 | |
| 16 | 2017 | 111 | |
| 17 | 2016 | 8 | |
| 18 | 2016 | 2 | |
| 19 | 2014 | 166 | |
| 20 | 2014 | 44 |
About Timothée Bruel
Timothée Bruel is a scholar working on Virology, Immunology and Infectious Diseases, having authored 54 papers that have together received 2.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (24 papers), Immune Cell Function and Interaction (21 papers), SARS-CoV-2 and COVID-19 Research (18 papers), COVID-19 Clinical Research Studies (14 papers), T-cell and B-cell Immunology (10 papers), SARS-CoV-2 detection and testing (8 papers), Immunotherapy and Immune Responses (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Virology (740 citations), Infectious Diseases (1.1k citations) and Immunology (907 citations). Timothée Bruel has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Olivier Schwartz, Nicoletta Casartelli, Hugo Mouquet, Florence Guivel‐Benhassine, Françoise Porrot, Jérémy Dufloo, Cyril Planchais, Delphine Planas, Blandine Monel and Julian Buchrieser. Their work appears in journals such as Journal of Virology, Nature Communications, The EMBO Journal, PLoS ONE and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.